Literature DB >> 21493786

Potent and systematic RNAi mediated silencing with single oligonucleotide compounds.

Jennifer Lapierre1, William Salomon, James Cardia, Karen Bulock, Jessica T Lam, William J Stanney, Glenna Ford, Bernice Smith-Anzures, Tod Woolf, Joanne Kamens, Anastasia Khvorova, Dmitry Samarsky.   

Abstract

RNA interference (RNAi) has been established as an important tool for functional genomics studies and has great promise as a therapeutic intervention for human diseases. In mammalian cells, RNAi is conventionally induced by 19-27-bp RNA duplexes generated by hybridization of two complementary oligonucleotide strands (oligos). Here we describe a novel class of RNAi molecules composed of a single 25-28-nucleotide (nt) oligo. The oligo has a 16-nt mRNA targeting region, followed by an additional 8-10 nt to enable self-dimerization into a partially complementary duplex. Analysis of numerous diverse structures demonstrates that molecules composed of two short helices separated by a loop can efficiently enter and activate the RNA-induced silencing complex (RISC). This finding enables the design of highly effective single-oligo compounds for any mRNA target.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21493786      PMCID: PMC3096035          DOI: 10.1261/rna.2399411

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  13 in total

1.  Identification of novel genes coding for small expressed RNAs.

Authors:  M Lagos-Quintana; R Rauhut; W Lendeckel; T Tuschl
Journal:  Science       Date:  2001-10-26       Impact factor: 47.728

2.  Synthetic shRNAs as potent RNAi triggers.

Authors:  Despina Siolas; Cara Lerner; Julja Burchard; Wei Ge; Peter S Linsley; Patrick J Paddison; Gregory J Hannon; Michele A Cleary
Journal:  Nat Biotechnol       Date:  2004-12-26       Impact factor: 54.908

3.  Cloning of short hairpin RNAs for gene knockdown in mammalian cells.

Authors:  Patrick J Paddison; Michele Cleary; Jose Maria Silva; Kenneth Chang; Nihar Sheth; Ravi Sachidanandam; Gregory J Hannon
Journal:  Nat Methods       Date:  2004-11       Impact factor: 28.547

4.  Gene silencing with siRNA duplexes composed of target-mRNA-complementary and partially palindromic or partially complementary single-stranded siRNAs.

Authors:  Markus Hossbach; Jens Gruber; Mary Osborn; Klaus Weber; Thomas Tuschl
Journal:  RNA Biol       Date:  2006-04-19       Impact factor: 4.652

5.  Potent RNAi by short RNA triggers.

Authors:  Chia-Ying Chu; Tariq M Rana
Journal:  RNA       Date:  2008-07-24       Impact factor: 4.942

Review 6.  Structural biology of RNA silencing and its functional implications.

Authors:  D J Patel; J-B Ma; Y-R Yuan; K Ye; Y Pei; V Kuryavyi; L Malinina; G Meister; T Tuschl
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2006

7.  Single-stranded antisense siRNAs guide target RNA cleavage in RNAi.

Authors:  Javier Martinez; Agnieszka Patkaniowska; Henning Urlaub; Reinhard Lührmann; Thomas Tuschl
Journal:  Cell       Date:  2002-09-06       Impact factor: 41.582

8.  Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex.

Authors:  Yanli Wang; Stefan Juranek; Haitao Li; Gang Sheng; Thomas Tuschl; Dinshaw J Patel
Journal:  Nature       Date:  2008-12-18       Impact factor: 49.962

9.  Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure.

Authors:  David H Mathews; Matthew D Disney; Jessica L Childs; Susan J Schroeder; Michael Zuker; Douglas H Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

Review 10.  The promises and pitfalls of RNA-interference-based therapeutics.

Authors:  Daniela Castanotto; John J Rossi
Journal:  Nature       Date:  2009-01-22       Impact factor: 49.962

View more
  7 in total

Review 1.  Silencing disease genes in the laboratory and the clinic.

Authors:  Jonathan K Watts; David R Corey
Journal:  J Pathol       Date:  2011-11-09       Impact factor: 7.996

2.  MicroRNA-31-3p Is Involved in Substance P (SP)-Associated Inflammation in Human Colonic Epithelial Cells and Experimental Colitis.

Authors:  Kai Fang; Ivy Ka Man Law; David Padua; Aristea Sideri; Vanessa Huang; Christopher G Kevil; Dimitrios Iliopoulos; Charalabos Pothoulakis
Journal:  Am J Pathol       Date:  2017-12-16       Impact factor: 4.307

Review 3.  The emerging role of miRNAs in inflammatory bowel disease: a review.

Authors:  Christopher G Chapman; Joel Pekow
Journal:  Therap Adv Gastroenterol       Date:  2015-01       Impact factor: 4.409

4.  Simultaneous cytosolic delivery of a chemotherapeutic and siRNA using nanoparticle-stabilized nanocapsules.

Authors:  Joseph Hardie; Ying Jiang; Emily R Tetrault; Phaedra C Ghazi; Gulen Yesilbag Tonga; Michelle E Farkas; Vincent M Rotello
Journal:  Nanotechnology       Date:  2016-08-09       Impact factor: 3.874

5.  Inhibition of HCV 5'-NTR and core expression by a small hairpin RNA delivered by a histone gene carrier, HPhA.

Authors:  Yanhua Ding; Hong Zhang; Yuxiang Li; Di Wu; Shumei He; Yang Wang; Yuanyuan Li; Feng Wang; Junqi Niu
Journal:  Int J Med Sci       Date:  2013-06-09       Impact factor: 3.738

6.  RNAi2013: RNAi at Oxford.

Authors:  Laura A Mulcahy; David Rf Carter
Journal:  J RNAi Gene Silencing       Date:  2013-05-20

Review 7.  Neurodegeneration as an RNA disorder.

Authors:  Rory Johnson; Wendy Noble; Gian Gaetano Tartaglia; Noel J Buckley
Journal:  Prog Neurobiol       Date:  2012-10-10       Impact factor: 11.685

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.